AVMR - AVRA Medical Robotics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.2450
0.0000 (0.00%)
At close: 3:17PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close0.2450
Open0.3000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2450 - 0.3000
52 Week Range0.1100 - 2.7900
Volume2,271
Avg. Volume2,838
Market Cap5.416M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0930
Earnings DateJun 29, 2020 - Jun 30, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • GlobeNewswire

    AVRA Medical Robotics, Inc. (OTC: AVMR) Updates Shareholders

    Despite the difficulties presented by the COVID-19 Pandemic, the Company continues to make progress on developing its proprietary Medical Robotic System. As AVRA CEO Barry Cohen explains, “The latest test results of AVRA’s Imaging and Detection System software designed to Detect, Identify, Diagnose, and Deliver an autonomous robotic surgical procedure continue to reinforce our confidence in our ability to develop an autonomous Medical Robotic System which should enable surgeons to sharply increase their productivity while also improving patient outcomes in the operating room of the future.”

  • GlobeNewswire

    AVRA Medical Robotics (OTC: AVMR) CEO Barry Cohen Acquires 1,000,000 Shares of Company Stock

    AVRA Medical Robotics, Inc. (the “Company”) (AVMR), an artificial intelligence company building a fully autonomous medical robotic system combining artificial intelligence, machine learning and proprietary software, today announces that its Chairman & CEO, Barry Cohen, has increased his stake in the company by approximately 5% by purchasing an additional 1,000,000 common shares of AVRA stock. The shares will be restricted.

  • GlobeNewswire

    AVRA Medical Robotics Clears Debt

    ORLANDO, Fla., Feb. 03, 2020 -- AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), a medical software and artificial intelligence company building a fully autonomous.

  • GlobeNewswire

    AVRA Medical Robotics Attends J.P. Morgan Healthcare Conference

    ORLANDO, Fla., Jan. 17, 2020 -- AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), a medical software and artificial intelligence company that is in the process of.

  • GlobeNewswire

    AVRA Medical Robotics Appoints Two World Renowned Professionals to Chair its Medical and Scientific Advisory Boards

    AVRA Medical Robotics, Inc. (the “Company”) (AVMR), an emerging company which is building a fully autonomous medical robotic system through the use of new technologies combining artificial intelligence, machine learning and proprietary software, announced today it has appointed Dr. Vipul Patel to Chair its Medical Advisory Board and Dr. Eytan Pollak to Chair the Scientific Advisory Board, effective immediately.

  • GlobeNewswire

    AVRA Medical Robotics Initiates Food and Drug Administration Approval Process

    The Company’s robot arm has already won approval in the EU and received the CE mark. The Company has begun implementing a quality and regulatory system that will serve as the foundation for US, Canadian, European, Australian, Japanese, and Brazilian market access for AVRA’s modern medical robotic system – a ground-breaking approach to medical robotics.

  • GlobeNewswire

    AVRA Medical Robotics Announces its Participation in 10th Annual Meeting of the Society of Robotic Surgery

    AVRA Medical Robotics, Inc. (the “Company”) (AVMR), an emerging company developing a proprietary software coded system that uses artificial intelligence and machine learning capabilities for the purpose of creating the next generation of fully autonomous medical robotic systems, announced today that its Chief Strategy Officer, D. Nikhil Shah, delivered a presentation at this year’s Annual Meeting of the Society of Robotic Surgery. Barry Cohen, Chairman and Chief Executive Officer of the Company, commented, “I was extremely pleased that we were able to share the AVRA story at this year’s meeting of the Society of Robotic Surgery.